Gregory Williams
2019 - Sevion Therapeutics
In 2019, Gregory Williams earned a total compensation of $2.7M as Chief Operating Officer at Sevion Therapeutics, a 55% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $165,000 |
|---|---|
| Option Awards | $1,758,250 |
| Salary | $409,375 |
| Stock Awards | $345,900 |
| Other | $12,327 |
| Total | $2,690,852 |
Williams received $1.8M in option awards, accounting for 65% of the total pay in 2019.
Williams also received $165K in non-equity incentive plan, $409.4K in salary, $345.9K in stock awards and $12.3K in other compensation.
Rankings
In 2019, Gregory Williams' compensation ranked 4,530th out of 13,971 executives tracked by ExecPay. In other words, Williams earned more than 67.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,530 out of 13,971 | 68th |
Division Manufacturing | 1,690 out of 5,701 | 70th |
Major group Chemicals And Allied Products | 590 out of 2,200 | 73rd |
Industry group Drugs | 496 out of 1,886 | 74th |
Industry Biological Products, Except Diagnostic Substances | 108 out of 389 | 72nd |
Source: SEC filing on April 1, 2020.
Williams' colleagues
We found three more compensation records of executives who worked with Gregory Williams at Sevion Therapeutics in 2019.